Factors associated with reduction of left ventricular mass in children on peritoneal dialysis

Jeong Jin Yu1, Hyun Ok Jun1, Eun Jung Shin1

  • 1Department of Pediatrics, University of Ulsan College of Medicine, Seoul, Korea.

Nephrology (Carlton, Vic.)
|February 16, 2017
PubMed

Insights

Fluid volume expansion significantly impacts left ventricular mass reduction in children with end-stage renal disease (ESRD) on peritoneal dialysis. Diastolic function and blood urea nitrogen levels are key indicators in this process.

Area of Science:

  • Pediatric Nephrology
  • Cardiology in Chronic Illness
  • Renal Disease Management

Background:

  • Left ventricular hypertrophy (LVH) is a significant complication in children with end-stage renal disease (ESRD).
  • Peritoneal dialysis (PD) is a common treatment modality for pediatric ESRD, but its effect on cardiac remodeling requires further investigation.
  • Understanding factors influencing left ventricular mass (LVM) changes is crucial for optimizing treatment and improving outcomes in these vulnerable patients.

Purpose of the Study:

  • To identify sensitive factors associated with left ventricular mass reduction in pediatric ESRD patients undergoing PD.
  • To explore the relationship between clinical and echocardiographic parameters and changes in indexed LVMI.
  • To elucidate the role of fluid volume status in cardiac remodeling during PD treatment.

Main Methods:

  • A cohort of 35 children with ESRD on PD was studied.
  • Two sets of serial echocardiographic and clinical data were collected for each participant.
  • Indexed left ventricular mass index (LVMI) and blood pressure were normalized using 95th percentile values for age and sex.

Main Results:

  • Systolic blood pressure index and E' velocity were identified as univariate predictors of left ventricular hypertrophy.
  • Changes in these predictors did not directly correlate with the change in indexed LVMI.
  • Reduction in indexed LVMI was significantly correlated with decreased indexed left atrial volume, reduced trans-mitral A velocity, lower serum blood urea nitrogen, and increased hemoglobin levels.

Conclusions:

  • Circulating volume expansion appears to be a primary factor influencing LVMI changes in pediatric ESRD patients on PD.
  • Volume-dependent diastolic functional variables are closely related to LVMI modifications.
  • Further research with larger cohorts, including fluid volume control groups, is warranted to confirm the role of volume expansion in LVMI changes.
Abstract

Related Concept Videos

Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.2K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.3K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.3K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
534
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K